By Dr. Syed Javaid Khurshid, Visiting Professor of Strategic Studies, National Defense University, Pakistan
Fentanyl was first developed in 1959 and introduced in the market in 1960. It...
By Mr. Frank Rando, CBRNE Protective & Biomedical Countermeasures SME, University of Arizona and Ms. Dee Ruelas, Clinical Specialist in COVID-19 testing and vaccination...
A Closer Look at Recent Russian Claims
By Zygmunt F. Dembek, Senior Scientist, Center for Disaster and Humanitarian Assistance Medicine, US.
Russia has claimed that the...
By Ilja M. Bonsen, Managing Director, NCT Consultants & Anna Paternnosto, President, CBRNe Society.
The NCT team is proud to present you the first issue...
Shai Arbel, CEO of Terrogence Global, provides a valuable update on CBRN terrorism with the aim of raising awareness and helping first responders and...
By BG (ret.) William King
Science and technology during the Cold War limited the United States and Soviet Union Chemical and Biological Weapons (CBW) programs...
Are We Ready?
By Dr. Mary Sproull, Research scientist, National Cancer Institute - National Institutes of Health, USA.
Since the events of 9/11, we have come...
…and no, it is not what you are thinking
By Mr. Luca Romano, Founder and Mr. Fulvio Buzzi, Vice-admin, L'Avvocato dell'Atomo, Italy.
Luca Romano and Fulvio...
By COL Paul Kassebaum, Commander, U.S. Army Medical Research Institute of Chemical Defense (MRICD), and Dr. James Dillman, Chief Science Officer, MRICD, USA.
The U.S....
Interview with Dr. Antonella Cavallo, rescEU CBRN Lead at EU Commission DG ECHO, the European Commission's Department for Civil Protection and Humanitarian Aid Operations
Dr....
By Aktiv Pharma Group.
Automatic self-injection devices used for administering first-line treatments for nerve agent poisoning and other life-threatening conditions are about to become a...
By Mr. Frank Rando, CBRNE Protective & Biomedical Countermeasures SME, University of Arizona and Ms. Dee Ruelas, Clinical Specialist in COVID-19 testing and vaccination...
